Bruce Bagley, an international studies professor, knew all about how corrupt Venezuelan officials were moving vast sums into South Florida. He cultivated contacts with Latin American policymakers, top criminal lawyers and U.S. anti-money-laundering officials. And, prosecutors say, he knew how to get a taste for himself.
The U.S. Department of Treasury’s Financial Crimes Enforcement Network (FinCEN) renewed its Geographic Targeting Orders (GTOs) for South Florida.
On Friday (Sept. 6), Google announced it would “prohibit advertising for unproven or experimental medical techniques such as most stem cell therapy, cellular (non-stem) therapy, and gene therapy.”
Last year, a Venezuelan banker was convicted of running a $1.2bn money- laundering scheme, all with stolen government money.
After brazenly taking ad money from health-care scammers, Google is finally saying no to ads for unproven stem-cell treatments.
Responding to ubiquitous online marketing by stem cell clinics selling unapproved treatments for everything from achy joints to Alzheimer’s, Google announced Friday it will no longer accept ads for “unproven or experimental medical techniques,” including most stem cell therapy, cellular therapy and gene therapy.
In May, the First District Court of Appeal, which covers parts of North Florida and the Panhandle, issued an opinion broadly construing the charitable purpose exemption in Florida’s ad valorem taxation regime.
In Pier 1 Cruise Experts v. Revelex Corp., 17-13956, 2019 WL 3024618, at *8 (11th Cir. July 11, 2019), the Eleventh Circuit Court of Appeals addressed the novel question of whether Florida law would enforce an exculpatory clause in a commercial contract that completely absolves one of the parties from all future liability.
There’s no denying that Facebook’s crypto plans are ambitious. They might even seem a bit outlandish.
In early May, a jury in Boston found that the founder of Insys Therapeutics, John Kapoor, as well as four other company executives, were guilty of a racketeering conspiracy.
